DESIGN THERAPEUTICS INC (DSGN) Stock Earnings & Estimates
NASDAQ:DSGN - US25056L1035 - Common Stock
6.45 USD
+0.34 (+5.56%)
6.45 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 830K | 230K -72.29% | -100.00% | 5.1M | 55.083M 980.06% | 222.55M 304.03% | 447.94M 101.28% | 722.98M 61.40% | |||||||
| EBITDA YoY % growth | N/A | -8.32M | -39.135M -329.09% | -69.3M -88.18% | -79.501M -15.31% | -92.31M 20.73% | -107.424M -74.95% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.91M | -8.33M -336.13% | -38.106M -330.13% | -69.193M -88.64% | -84.211M -15.40% | -63.769M 20.51% | -87.055M -40.41% | -94.21M -8.22% | -121.863M -29.35% | -180.27M -47.93% | -202.478M -12.32% | -104.744M 48.27% | 65.515M 162.55% | 289.05M 341.20% | |
| Operating Margin | -230.12% | -3,621.74% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -3,534.70% | -367.59% | -47.07% | 14.63% | 39.98% | |
| EPS YoY % growth | N/A | N/A | -0.82 | -1.19 -32.56% | -1.32 -5.26% | -0.92 26.67% | -1.36 -54.93% | -1.24 8.98% | -1.44 -16.16% | -1.64 -13.92% | -1.26 22.98% | -0.43 66.13% | 0.62 245.24% | 1.83 194.26% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.35 -52.26% | -0.35 -45.92% | -0.35 -13.52% | -0.36 -5.00% | -0.36 -3.40% | -0.37 -6.31% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -22.083M -35.93% | -22.107M -32.42% | -22.164M -8.55% | -22.604M -4.80% | -22.916M -3.77% | -23.287M -5.34% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.34 -61.90% | -0.34 | 0.00 | -1.01% |
| Q1 2025 Q2Q % growth | -0.31 -55.00% | -0.29 | -0.02 | -8.54% |
| Q4 2024 Q2Q % growth | -0.24 -14.29% | -0.27 | 0.03 | 11.77% |
| Q3 2024 Q2Q % growth | -0.23 17.86% | -0.25 | 0.02 | 7.33% |
| Q2 2024 Q2Q % growth | -0.21 41.67% | -0.24 | 0.03 | 11.76% |
| Q1 2024 Q2Q % growth | -0.20 42.86% | -0.27 | 0.07 | 25.54% |
| Q4 2023 Q2Q % growth | -0.21 32.26% | -0.32 | 0.11 | 33.53% |
| Q3 2023 Q2Q % growth | -0.28 12.50% | -0.42 | 0.14 | 32.80% |
| Q2 2023 Q2Q % growth | -0.36 -33.33% | -0.41 | 0.05 | 11.21% |
| Q1 2023 Q2Q % growth | -0.35 -45.83% | -0.37 | 0.02 | 4.49% |
| Q4 2022 Q2Q % growth | -0.31 -55.00% | -0.35 | 0.04 | 11.65% |
| Q3 2022 Q2Q % growth | -0.32 -52.38% | -0.29 | -0.03 | -8.93% |
| Q2 2022 Q2Q % growth | -0.27 -92.86% | -0.26 | -0.02 | -5.88% |
| Q1 2022 Q2Q % growth | -0.24 22.58% | -0.22 | -0.02 | -6.95% |
| Q4 2021 Q2Q % growth | -0.20 | -0.23 | 0.03 | 13.50% |
| Q3 2021 Q2Q % growth | -0.21 | -0.14 | -0.07 | -47.06% |
| Q2 2021 Q2Q % growth | -0.14 | -0.19 | 0.05 | 25.13% |
| Q1 2021 Q2Q % growth | -0.31 | -0.07 | -0.24 | -314.46% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.98% | -16.38% | -0.5% | -0.5% |
| Revenue | N/A | N/A | N/A | N/A |